title: [Diagnosis, therapy and secondary prophylaxis of acute pulmonary embolism. Presentation of and commentary on the new ESC 2008 guidelines].
abstract: Acute venous thromboembolism is a common cardiovascular emergency. Acute pulmonary embolism (PE) is present in one third of these patients. With an average lethality rate of 11% within the first two weeks following diagnosis, approximately 40,000 patients in Germany die annually as a result of PE; therefore, their diagnosis and therapy is of particular importance. For this reason, the European Society of Cardiology published guidelines on diagnosis and therapy in 2000. The current article presents and discusses the points as updated and extended in the 2008 version of the guidelines, including: (1) initial risk stratification--when PE is already suspected; (2) diagnostic procedures and algorithms; (3) further risk stratification; (4) therapeutic strategies in the acute phase; (5) further management and (6) long-term anticoagulation and secondary prophylaxis.
authors.affiliation: Klinik für Anaesthesiologie, Universitätsklinikum Heidelberg, Heidelberg.
authors.forename: A
authors.initials: A
authors.lastname: Walther
authors.forename: A
authors.initials: A
authors.lastname: Schellhaass
authors.forename: B W
authors.initials: BW
authors.lastname: Böttiger
authors.forename: S
authors.initials: S
authors.lastname: Konstantinides
mesh_terms: D000208:Acute Disease; D000465:Algorithms; D000925:Anticoagulants / Q000627:therapeutic use; D005062:European Union; D005858:Germany / Q000453:epidemiology; D006801:Humans; D007431:Intraoperative Complications / Q000175:diagnosis / Q000517:prevention & control / Q000628:therapy; D008134:Long-Term Care; D011655:Pulmonary Embolism / Q000175:diagnosis* / Q000517:prevention & control / Q000628:therapy*; D018570:Risk Assessment
chemical_list: D000925:Anticoagulants